Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 15/20 | 0.72 |
| ▸ | FAAH | O00519 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.50 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15313039 | 0.84 | PLA2G2C (0.60) | FAAHMEN1MAPK1KMT2APLA2G2C | |
| SCHEMBL27631040 | 0.84 | NOD1 (0.55) | NOD1KMT2A | |
| SCHEMBL9632841 | 0.83 | FAAH (0.56) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL7209829 | 0.81 | SLC6A5 (0.59) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL7215943 | 0.81 | SLC6A5 (0.59) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL7215978 | 0.81 | SLC6A5 (0.59) | NOD1FAAHMEN1MAPK1KMT2A | |
| Propionic Acid SCHEMBL28384875 | 0.81 | PLA2G2C (0.56) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL4626879 | 0.81 | NOD1 (0.85) | NOD1SLC6A5 | |
| SCHEMBL27736241 | 0.80 | MEN1 (0.52) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL16860739 | 0.80 | NOD1 (0.76) | NOD1FAAHDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040208919-A1 | Vaccination against prion diseases | NICOLAU YVES C (US) | 2004-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040208919-A1 | Vaccination against prion diseases | PRNP, APP, PRPH | NOD1 1542/4885FAAH 620/4885MEN1 3967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.